🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Stock Summary and Key Metrics













Investment Checklist




























Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

View Standalone

Total Figures
QoQ Changes
Total Figures
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales17141618371921212020
Expenses16131417341719212118
Operating Profit1.311.481.541.622.792.012.000.67-0.891.59
OPM %7.6510.399.818.897.4910.509.353.14-4.368.01
Other Income0.080.090.140.130.040.110.080.290.580.34
Interest0.090.130.160.180.280.260.272.362.061.90
Depreciation0.070.070.080.080.210.240.280.621.951.43
Profit Before Tax1.231.381.441.492.341.621.52-2.01-4.31-1.40
Tax %29.2726.0928.4727.5230.3427.7823.68-23.38-4.41-20.00
Net Profit0.871.021.041.081.631.171.17-2.49-4.51-1.68
EPS in Rs0.871.021.041.081.631.171.17-0.68-1.65-0.22

Consolidated Profit Loss (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales0.009.9582707476719699
Expenses0.349.2978656971668892
Operating Profit-0.340.664.354.775.005.255.828.427.47
OPM %6.635.316.846.746.898.158.777.54
Other Income0.390.360.050.180.310.510.400.360.52
Interest0.000.011.101.280.870.620.491.003.17
Depreciation0.000.000.100.140.210.200.290.811.35
Profit Before Tax0.051.013.203.534.234.945.446.973.47
Tax %36.3426.8326.3927.0626.7327.0127.4227.4857.35
Net Profit0.030.742.362.583.103.613.955.061.48
EPS in Rs0.762.362.583.103.683.955.05-1.38
Dividend Payout %0.000.000.000.000.001.782.530.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital3.253.253.253.253.25101010
Reserves0.020.753.116.299.39313539
Borrowings0.020.11138.968.634.724.8517
Other Liabilities0.625.01171211136.1610
Total Liabilities3.919.13363132595676
Fixed Assets0.010.001.682.352.362.573.524.75
CWIP0.000.000.000.000.000.000.000.00
Investments0.000.000.000.160.010.020.023.96
Other Assets3.909.13342830565367
Total Assets3.919.13363132595676

Consolidated Cash Flows (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity0.020.93-145.823.85-105.58-7.11
Cash from Investing Activity0.000.000.00-0.94-1.30-5.38-8.54-2.19
Cash from Financing Activity0.000.0913-5.14-1.2020-0.468.63
Net Cash Flow0.021.02-0.40-0.261.354.92-3.42-0.68

Documents

Presentations
Concalls
Reports
Presentations

No documents found!

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Medico Intercontinental Ltd

Medico Intercontinental Ltd (MIL) is currently trading at 32.07 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Medico Intercontinental Limited specializes in the trading of pharmaceutical products. The company acts as a platform for bio-pharmaceutical companies, facilitating global access to novel therapies. Medico's focus includes using advanced scientific technology aimed at discovering new treatments for rare diseases. The company is deeply committed to improving patient outcomes, prioritizing patient needs in their innovative medical pursuits.,

Over the past 52 weeks, Medico Intercontinental Ltd has traded between a low of ₹26.00 and a high of ₹49.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medico Intercontinental Ltd has a market capitalization of approximately 33.75. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medico Intercontinental Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -23.24 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 33.75 Cr, Medico Intercontinental Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medico Intercontinental Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medico Intercontinental Ltd is -23.24. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.